GE HEALTHCARE TECHNOLOGY (GEHC) Stock Earnings Estimates
NASDAQ:GEHC • US36266G1076
80.16 USD
-4.11 (-4.88%)
At close: Mar 2, 2026
79.49 USD
-0.67 (-0.84%)
Pre-Market: 3/3/2026, 7:40:13 AM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.552B 6.60% | 19.672B 0.61% | 20.625B 4.84% | 22.1B 7.15% | 23.102B 4.53% | 24.207B 4.78% | 24.279B 0.30% | 24.388B 0.45% | |
| EBITDA YoY % growth | 3.045B -3.49% | 3.205B 5.25% | 3.341B 4.24% | 4.061B 21.55% | 4.362B 7.41% | 4.694B 7.61% | 4.91B 4.60% | N/A | |
| EBIT YoY % growth | 2.435B -3.45% | 2.625B 7.80% | 2.763B 5.26% | 3.437B 24.39% | 3.717B 8.15% | 4.041B 8.72% | N/A | N/A | |
| Operating Margin | 12.45% | 13.34% | 13.40% | 15.55% | 16.09% | 16.69% | N/A | N/A | |
| EPS YoY % growth | 3.94 10.02% | 4.49 13.96% | 4.58 2.00% | 5.02 9.67% | 5.61 11.75% | 6.12 8.99% | 6.46 5.54% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.08 7.05% | 1.19 12.28% | 1.28 19.77% | 1.54 6.86% | 1.19 10.38% | 1.29 7.98% | 1.36 5.86% | 1.75 14.01% |
| Revenue Q2Q % growth | 5.136B 7.52% | 5.369B 7.23% | 5.43B 5.58% | 5.942B 4.28% | 5.472B 6.54% | 5.581B 3.95% | 5.683B 4.66% | 6.275B 5.60% |
| EBITDA Q2Q % growth | 888.11M 16.09% | 939.71M 0.18% | 997.21M -8.09% | 1.16B -17.44% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 732.98M 16.53% | 803.02M 22.79% | 842.97M 29.09% | 1.021B 23.46% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 1.44 -0.69% | 1.43 | 0.01 | 0.96% |
| Q3 2025 Q2Q % growth | 1.07 -6.14% | 1.07 | 0.00 | -0.16% |
| Q2 2025 Q2Q % growth | 1.06 6.00% | 0.94 | 0.12 | 13.24% |
| Q1 2025 Q2Q % growth | 1.01 12.22% | 0.93 | 0.08 | 8.42% |
| Q4 2024 Q2Q % growth | 1.45 22.88% | 1.29 | 0.16 | 12.49% |
| Q3 2024 Q2Q % growth | 1.14 15.15% | 1.07 | 0.07 | 6.17% |
| Q2 2024 Q2Q % growth | 1.00 8.70% | 1.00 | 0.00 | 0.18% |
| Q1 2024 Q2Q % growth | 0.90 5.88% | 0.92 | -0.02 | -2.68% |
| Q4 2023 Q2Q % growth | 1.18 -9.92% | 1.09 | 0.09 | 8.08% |
| Q3 2023 Q2Q % growth | 0.99 | 0.91 | 0.08 | 8.23% |
| Q2 2023 Q2Q % growth | 0.92 | 0.89 | 0.03 | 3.67% |
| Q1 2023 Q2Q % growth | 0.85 | 0.81 | 0.04 | 5.15% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 5.698B 7.13% | 5.723B | -25M | -0.44% |
| Q3 2025 Q2Q % growth | 5.143B 5.76% | 5.182B | -39M | -0.75% |
| Q2 2025 Q2Q % growth | 5.007B 3.47% | 5.062B | -55M | -1.09% |
| Q1 2025 Q2Q % growth | 4.777B 2.73% | 4.757B | 20M | 0.42% |
| Q4 2024 Q2Q % growth | 5.319B 2.17% | 5.437B | -118M | -2.17% |
| Q3 2024 Q2Q % growth | 4.863B 0.85% | 4.966B | -103M | -2.07% |
| Q2 2024 Q2Q % growth | 4.839B 0.46% | 4.97B | -131M | -2.64% |
| Q1 2024 Q2Q % growth | 4.65B -1.21% | 4.897B | -247M | -5.04% |
| Q4 2023 Q2Q % growth | 5.206B 5.43% | 5.193B | 13M | 0.25% |
| Q3 2023 Q2Q % growth | 4.822B 5.38% | 4.901B | -79M | -1.61% |
| Q2 2023 Q2Q % growth | 4.817B -45.43% | 4.89B | -73M | -1.49% |
| Q1 2023 Q2Q % growth | 4.707B | 4.727B | -20M | -0.42% |
| Q4 2022 Q2Q % growth | 4.938B 7.61% | % | ||
| Q3 2022 Q2Q % growth | 4.576B 6.32% | % | ||
| Q2 2022 Q2Q % growth | 8.827B 1.55% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 6.22% | 4.69% | -0.23% | -0.37% |
| Revenue | 0.61% | 0.61% | 1.18% | 1.09% |